dioscin has been researched along with Benign Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, U; Bandopadhyay, S; Behl, T; Dey, A; Gadekar, VS; Gupta, PK; Jha, NK; Kumar, M; Shekhawat, MS | 1 |
| Jiang, W; Lin, M; Wang, Z | 1 |
| Peng, J; Qi, Y; Tao, X; Xu, L; Yin, L; Zhao, L | 1 |
| Peng, J; Tao, X; Xu, L; Yin, L | 1 |
| Dong, D; Han, X; Peng, J; Qi, Y; Xu, L; Xu, Y; Yin, L; Zhao, Y; Zheng, L | 1 |
2 review(s) available for dioscin and Benign Neoplasms
| Article | Year |
|---|---|
Dioscin: A review on pharmacological properties and therapeutic values.
Topics: Diosgenin; Humans; Neoplasms; Plant Extracts; Saponins | 2022 |
Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Diosgenin; Humans; Metabolic Diseases; Neoplasms | 2018 |
3 other study(ies) available for dioscin and Benign Neoplasms
| Article | Year |
|---|---|
Dioscin: A new potential inhibitor of Skp2 for cancer therapy.
Topics: Animals; Biological Products; Cell Line, Tumor; Diosgenin; Humans; Mice; Neoplasms; S-Phase Kinase-Associated Proteins; Xenograft Model Antitumor Assays | 2020 |
Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.
Topics: Animals; Apoptosis; Cardiotoxicity; Cell Survival; Diosgenin; Doxorubicin; Gene Expression Regulation, Neoplastic; Mice; MicroRNAs; Myocardium; Neoplasm Proteins; Neoplasms; Oxidative Stress; Rats | 2018 |
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cell Cycle; Computational Biology; Dioscorea; Diosgenin; DNA Topoisomerases, Type I; Down-Regulation; Drugs, Chinese Herbal; Epidermal Growth Factor; ErbB Receptors; Gene Regulatory Networks; Humans; Male; MAP Kinase Signaling System; Mice; Neoplasms; Phytotherapy; Protein Binding; Rats; Signal Transduction | 2015 |